Home

monter accueil Sitcom mycn amplification Persistance Laquelle Opportun

Webpathology.com: A Collection of Surgical Pathology Images
Webpathology.com: A Collection of Surgical Pathology Images

MYCN amplification and ATRX mutations are incompatible in neuroblastoma |  Nature Communications
MYCN amplification and ATRX mutations are incompatible in neuroblastoma | Nature Communications

The super elongation complex drives transcriptional addiction in MYCN- amplified neuroblastoma | Science Advances
The super elongation complex drives transcriptional addiction in MYCN- amplified neuroblastoma | Science Advances

Implementation of Novel Mode for Evaluation of MYCN Amplification that can  Predict Outcome in Patients with Neuroblastoma | Clinical Oncology and  Research | Science Repository | Open Access
Implementation of Novel Mode for Evaluation of MYCN Amplification that can Predict Outcome in Patients with Neuroblastoma | Clinical Oncology and Research | Science Repository | Open Access

MYCN (n-myc) | Cancer Genetics Web
MYCN (n-myc) | Cancer Genetics Web

MYCN gain and MYCN amplification in a stage 4S neuroblastoma - ScienceDirect
MYCN gain and MYCN amplification in a stage 4S neuroblastoma - ScienceDirect

The roles played by the MYCN, Trk, and ALK genes in neuroblastoma and  neural development | SpringerLink
The roles played by the MYCN, Trk, and ALK genes in neuroblastoma and neural development | SpringerLink

Cancers | Free Full-Text | Extracellular Vesicle-Based Method for Detecting MYCN  Amplification Status of Pediatric Neuroblastoma
Cancers | Free Full-Text | Extracellular Vesicle-Based Method for Detecting MYCN Amplification Status of Pediatric Neuroblastoma

ALK pERKs Up MYCN in Neuroblastoma | Science Signaling
ALK pERKs Up MYCN in Neuroblastoma | Science Signaling

Frontiers | Molecular Mechanisms of MYCN Dysregulation in Cancers
Frontiers | Molecular Mechanisms of MYCN Dysregulation in Cancers

JCI - CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency  on EZH2
JCI - CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2

The MYCN oncogene and differentiation in neuroblastoma - ScienceDirect
The MYCN oncogene and differentiation in neuroblastoma - ScienceDirect

A new approach to predict the presence of MYCN gene amplification in  pediatric brain tumors by analyzing RNA molecules | ASPIC
A new approach to predict the presence of MYCN gene amplification in pediatric brain tumors by analyzing RNA molecules | ASPIC

XL MYCN amp - Amplification Probe | MetaSystems Probes
XL MYCN amp - Amplification Probe | MetaSystems Probes

Interplay between MycN and c-Myc regulates radioresistance and cancer stem  cell phenotype in neuroblastoma upon glutamine deprivation
Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation

Webpathology.com: A Collection of Surgical Pathology Images
Webpathology.com: A Collection of Surgical Pathology Images

Concurrent targeting of MAP3K3 and BRD4 by miR-3140-3p overcomes acquired  resistance to BET inhibitors in neuroblastoma cells: Molecular Therapy -  Nucleic Acids
Concurrent targeting of MAP3K3 and BRD4 by miR-3140-3p overcomes acquired resistance to BET inhibitors in neuroblastoma cells: Molecular Therapy - Nucleic Acids

Redefining functional MYCN gene signatures in neuroblastoma | PNAS
Redefining functional MYCN gene signatures in neuroblastoma | PNAS

MYCN amplification and International Neuroblastoma Risk Group  stratification on fine-needle aspiration biopsy and their correlation to  survival in neuroblastoma | Journal of Clinical Pathology
MYCN amplification and International Neuroblastoma Risk Group stratification on fine-needle aspiration biopsy and their correlation to survival in neuroblastoma | Journal of Clinical Pathology

MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to an  ROS augmenting agent | Cell Death & Disease
MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to an ROS augmenting agent | Cell Death & Disease

IJMS | Free Full-Text | Targeting Oncogenic Transcriptional Networks in  Neuroblastoma: From N-Myc to Epigenetic Drugs
IJMS | Free Full-Text | Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic Drugs

The Mechanism by Which MYCN Amplification Confers an Enhanced Sensitivity  to a PCNA-Derived Cell Permeable Peptide in Neuroblastoma Cells -  eBioMedicine
The Mechanism by Which MYCN Amplification Confers an Enhanced Sensitivity to a PCNA-Derived Cell Permeable Peptide in Neuroblastoma Cells - eBioMedicine

Frontiers | MYCN Function in Neuroblastoma Development
Frontiers | MYCN Function in Neuroblastoma Development

XL MYCN amp - Amplification Probe | MetaSystems Probes
XL MYCN amp - Amplification Probe | MetaSystems Probes

Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN  amplification | PNAS
Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification | PNAS

N-MYC (MYCN) amplification in neuroblastomas – آزمایشگاه پرتولب
N-MYC (MYCN) amplification in neuroblastomas – آزمایشگاه پرتولب

MYCN amplification predicts poor prognosis based on interphase fluorescence  in situ hybridization analysis of bone marrow cells in bone marrow  metastases of neuroblastoma | Cancer Cell International | Full Text
MYCN amplification predicts poor prognosis based on interphase fluorescence in situ hybridization analysis of bone marrow cells in bone marrow metastases of neuroblastoma | Cancer Cell International | Full Text